Related Experiment Video
Updated: May 9, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Mechanisms of the androgen receptor splicing in prostate cancer cells
1Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
Prostate tumors develop resistance to androgen deprivation therapy (ADT) by multiple mechanisms, one of which is to express constitutively active androgen receptor (AR) splice variants lacking the ligand-binding domain. AR splice variant 7 (AR-V7, also termed AR3) is the most abundantly expressed variant that drives prostate tumor progression under ADT conditions. However, the molecular mechanism by which AR-V7 is generated remains unclear. In this manuscript, we demonstrated that RNA splicing of AR-V7 in response to ADT was closely associated with AR gene transcription initiation and elongation rates. Enhanced AR gene transcription by ADT provides a prerequisite condition that further increases the interactions between AR pre-mRNA and splicing factors. Under ADT conditions, recruitment of several RNA splicing factors to the 3' splicing site for AR-V7 was increased. We identified two RNA splicing enhancers and their binding proteins (U2AF65 and ASF/SF2) that had critical roles in splicing AR pre-mRNA into AR-V7. These data indicate that ADT-induced AR gene transcription rate and splicing factor recruitment to AR pre-mRNA contribute to the enhanced AR-V7 levels in prostate cancer cells.
Insights
Androgen deprivation therapy resistance in prostate cancer involves androgen receptor (AR) splice variants. This study reveals ADT increases AR gene transcription and splicing factor recruitment, enhancing AR-V7 production.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Prostate tumors develop resistance to androgen deprivation therapy (ADT) through mechanisms including constitutively active androgen receptor (AR) splice variants.
- AR splice variant 7 (AR-V7) is a key driver of prostate tumor progression under ADT, but its generation mechanism is unclear.
Purpose of the Study:
- To elucidate the molecular mechanism behind AR-V7 generation in prostate cancer cells under ADT.
- To investigate the relationship between AR gene transcription, RNA splicing, and AR-V7 production.
Main Methods:
- Analysis of AR gene transcription initiation and elongation rates under ADT.
- Assessment of RNA splicing factor recruitment to AR pre-mRNA.
- Identification of RNA splicing enhancers and binding proteins involved in AR-V7 formation.
Main Results:
- ADT enhances AR gene transcription, creating conditions for increased AR pre-mRNA and splicing factor interactions.
- Recruitment of specific RNA splicing factors to the 3' splicing site for AR-V7 is increased under ADT.
- Two RNA splicing enhancers and their binding proteins (U2AF65 and ASF/SF2) were identified as critical for AR-V7 splicing.
Conclusions:
- ADT-induced increases in AR gene transcription rate contribute to enhanced AR-V7 levels.
- Increased splicing factor recruitment to AR pre-mRNA is a key mechanism for AR-V7 generation.
- Understanding these mechanisms offers potential therapeutic targets for overcoming ADT resistance in prostate cancer.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
What is Gene Expression?

